Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Propofol Anesthesia

Clinical trial NCT07044180 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07044180
Sponsor: Tamas Vegh, MD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Neuromuscular Blocking Agents Residual Neuromuscular Block Reversal of Neuromuscular Blockade

Start date: 2025-06-26
Primary completion: 2028-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.